Sogra R Saleem, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Mark Cermele Ct, Lawrenceville, NJ 08648 Phone: 732-577-8790 Fax: 732-409-7517 |
Dr. Leslie D. Mechanic, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 3131 Princeton Pike, Building S Suite 110, Lawrenceville, NJ 08648 Phone: 609-895-0933 |
Dr. Frank Campo, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 1028 Lawrence Rd, Lawrenceville, NJ 08648 Phone: 609-882-7812 |
News Archive
Rainbow Coral Corp. announced today that it has established the headquarters of its new biotechnology division—Rainbow BioSciences, LLC—in Houston, Texas, home of the world's largest medical complex.
Cempra Pharmaceuticals today announced poster presentations on its novel antibiotic CEM-101, a next-generation macrolide, and CEM-102, the company's proprietary front-loading oral dosing regimen of sodium fusidate, at the 20th European Congress of Clinical Microbiology and Infectious Disease, April 10 to 13, 2010, in Vienna Austria.
Alex's Lemonade Stand Foundation, a nonprofit foundation devoted to finding cures for all children with cancer, announces grant award recipients of their Crazy 8 Initiative.
In the 40 years between 1970-2010, the proportion of patients with diabetes undergoing coronary artery bypass grafting (CABG) escalated from 7% to 37%. The results of a large study from Cleveland Clinic just published in The Journal of Thoracic and Cardiovascular Surgery, the official publication of the American Association for Thoracic Surgery, documents the five-fold increase in the proportion of patients with diabetes undergoing this procedure between 1970 and 2010.
Onconova Therapeutics®, Inc. announced agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) for the design of a pivotal Phase 3 trial for Estybon™ (ON 01910.Na) as monotherapy in patients with myelodysplastic syndromes (MDS), diseases affecting the production of healthy blood cells in the bone marrow.
› Verified 2 days ago